A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet

NCT07374224 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Clinical Pharmacology

Interventions

DRUG: Rocbrutinib tablets
DRUG: Itraconazole capsules
DRUG: Rifampicin capsules

Sponsor

Guangzhou Lupeng Pharmaceutical Company LTD.